Understanding the Medicines Verification Organisation in relation to The National Medicines Verification Organisation (NMV0) and The European Medicines Verification Organisation (EMVO)

  • What are Aggregated Codes?
  • What is the “10-day rule” For “ Re-commissioning “ Medicinal products?
  • Over view of Stabilisation Periods- Selection of countries from – GIRP notification 5th February 2019
  • Importation of Active Substances
  • Are the rules tougher on the import of active pharmaceutical ingredients?
  • Why is the Registration of ‘Brokers’ important?
  • Requirement for Distance sellers of medicines?
  • When should a wholesaler decommission medicinal products?
  • What is the Verification and Decommissioning Process?
  • Wholesale Distributors and the FMD?
  • Unique Identifier (UI)
  • What is the EMVS to NMVS Process Flow?
  • Marketing Authorisation Holders:
    • 1) Recall, 2) Theft, 3) Withdrawal, 4) Sampling, 5) Repackaging, 6) Re-labelling of medicinal products
  • How to implement and execute your own FMD Plan?
  • What of FMD in the Event of a No-Deal Brexit?
  • Distance Sellers of Medicines in relation to FMD?
  • Who is exactly authorised or entitled to supply medicines to the public?
  • Additional Falsified Medicines Directive measures
  • Requirement is waived for certain third countries specified by the Commission

And much more…

To ask any questions or to book onto this course please contact info@pharmacyconsulting.co.uk